Tutorials › Biostatistics › One-Sample and Two-Sample t-Tests in Clinical Data

Clinical Trial Statistics

One-Sample and Two-Sample t-Tests in Clinical Data

A practical guide to using one-sample and two-sample t-tests in clinical research, including hypotheses, assumptions, pooled versus Welch methods, paired data, confidence intervals, effect sizes, interpretation, and implementation in R and SAS.

Intermediate 16 min read

What You'll Learn

  • When to use a one-sample versus two-sample t-test
  • How the t-statistic and degrees of freedom are calculated
  • The difference between pooled and Welch two-sample tests
  • How paired t-tests differ from independent two-sample tests
  • How confidence intervals and effect sizes complement p-values
  • How to implement t-tests in R and SAS

Introduction

The t-test is one of the most familiar statistical methods in biostatistics. Despite its simplicity, it remains useful in clinical research when the scientific question involves comparing a continuous outcome with a reference value or comparing the means of two groups.

Examples occur throughout clinical development. A study may ask whether the mean change in a laboratory measurement differs from zero, whether the mean change in a treatment group differs from a clinically relevant reference value, or whether the mean outcome differs between two treatment groups.

The correct version of the t-test depends primarily on the study design and scientific question, not simply on the fact that the outcome is continuous.

Key idea: A one-sample t-test compares one sample mean with a specified reference value. An independent two-sample t-test compares the means of two independent groups. A paired t-test compares within-subject differences when observations are naturally paired.

The Three Common t-Test Settings

Test Clinical question Basic comparison
One-sample t-test Does the sample mean differ from a specified value? Mean vs. reference
Independent two-sample t-test Do two independent groups have different means? Mean A vs. Mean B
Paired t-test Does the mean within-patient change differ from zero? Mean of paired differences vs. zero

One-Sample t-Test

Suppose a clinical study measures a continuous biomarker in a group of patients. The investigator wants to determine whether the population mean differs from a specified reference value.

Let the observations be:

Observed sample
\[ X_1,X_2,\ldots,X_n \]

The sample mean is:

\[ \bar{X}=\frac{1}{n}\sum_{i=1}^{n}X_i \]

and the sample standard deviation is:

\[ s=\sqrt{\frac{1}{n-1}\sum_{i=1}^{n}(X_i-\bar{X})^2} \]

The one-sample t-test evaluates whether the population mean is equal to a specified value \(\mu_0\).

Hypotheses

For a two-sided test:

\[ H_0:\mu=\mu_0 \] \[ H_A:\mu\neq\mu_0 \]

The null hypothesis states that the population mean equals the reference value. The alternative hypothesis states that the population mean differs from it.

For example, suppose a biomarker has a clinically relevant reference value of 50 units. The hypotheses could be:

\[ H_0:\mu=50 \] \[ H_A:\mu\neq50 \]

The One-Sample t-Statistic

The test statistic is:

\[ t=\frac{\bar{X}-\mu_0}{s/\sqrt{n}} \]

The numerator represents the observed difference between the sample mean and the hypothesized population mean. The denominator is the estimated standard error of the sample mean.

Under the null hypothesis, the statistic follows a t-distribution with:

\[ df=n-1 \]

degrees of freedom.

Interpretation: The t-statistic measures how many estimated standard errors the observed sample mean is away from the hypothesized reference value.

One-Sample Clinical Example

Suppose 25 patients have a mean change in a laboratory measurement of \(-4.2\) units, with a standard deviation of \(8.0\) units. The investigator wants to test whether the mean change differs from zero.

The hypotheses are:

\[ H_0:\mu=0 \] \[ H_A:\mu\neq0 \]

The standard error is:

\[ SE=\frac{8.0}{\sqrt{25}}=1.6 \]

The t-statistic is therefore:

\[ t=\frac{-4.2-0}{1.6}=-2.625 \]

The degrees of freedom are:

\[ df=25-1=24 \]

The resulting p-value can then be compared with the prespecified significance level, such as \(\alpha=0.05\).

Clinical interpretation: A statistically significant result would indicate evidence that the population mean change differs from zero. It would not, by itself, establish that the change is clinically important.

Confidence Interval for a One-Sample Mean

A confidence interval is often more informative than a p-value alone because it shows the range of population mean values compatible with the data under the chosen confidence level.

A two-sided \(100(1-\alpha)\%\) confidence interval for the population mean is:

\[ \bar{X}\pm t_{1-\alpha/2,\,n-1}\frac{s}{\sqrt{n}} \]

For example, a 95% confidence interval is:

\[ \bar{X}\pm t_{0.975,\,n-1}\frac{s}{\sqrt{n}} \]

If the confidence interval excludes zero, the corresponding two-sided test of \(H_0:\mu=0\) at the 0.05 significance level will reject the null hypothesis.

Two-Sample t-Test

The independent two-sample t-test is used when the outcome is measured in two independent groups.

A common clinical-trial example is comparison of a continuous endpoint between an experimental treatment arm and a control arm.

Group Example Outcome
Treatment Drug A Change from baseline in biomarker
Control Placebo Change from baseline in biomarker

Let:

\[ \bar{X}_1,\quad s_1,\quad n_1 \]

represent the sample mean, standard deviation, and sample size for Group 1, and:

\[ \bar{X}_2,\quad s_2,\quad n_2 \]

represent the corresponding quantities for Group 2.

The primary quantity of interest is the difference in means:

\[ \Delta=\mu_1-\mu_2 \]

Hypotheses

For a two-sided comparison:

\[ H_0:\mu_1-\mu_2=0 \] \[ H_A:\mu_1-\mu_2\neq0 \]

A one-sided hypothesis can also be specified when scientifically justified and prespecified.

Pooled Two-Sample t-Test

The traditional pooled two-sample t-test assumes that the two populations have the same variance.

The pooled variance estimate is:

\[ s_p^2= \frac{(n_1-1)s_1^2+(n_2-1)s_2^2} {n_1+n_2-2} \]

The pooled standard error for the difference in means is:

\[ SE(\bar{X}_1-\bar{X}_2) = s_p\sqrt{\frac{1}{n_1}+\frac{1}{n_2}} \]

The test statistic is:

\[ t= \frac{\bar{X}_1-\bar{X}_2} {s_p\sqrt{\frac{1}{n_1}+\frac{1}{n_2}}} \]

with:

\[ df=n_1+n_2-2 \]
Important: The pooled test treats the population variances as equal. That assumption is not generally necessary for comparing two means.

Welch's Two-Sample t-Test

Welch's t-test does not require the two populations to have equal variances. This makes it a particularly useful default for many two-group comparisons.

The Welch standard error is:

\[ SE= \sqrt{ \frac{s_1^2}{n_1} + \frac{s_2^2}{n_2} } \]

The test statistic is:

\[ t= \frac{\bar{X}_1-\bar{X}_2} {\sqrt{ \frac{s_1^2}{n_1} + \frac{s_2^2}{n_2} }} \]

The Welch-Satterthwaite approximation gives the degrees of freedom:

\[ df= \frac{ \left( \frac{s_1^2}{n_1}+ \frac{s_2^2}{n_2} \right)^2 }{ \frac{ \left(s_1^2/n_1\right)^2 }{n_1-1} + \frac{ \left(s_2^2/n_2\right)^2 }{n_2-1} } \]

The resulting degrees of freedom need not be an integer.

Pooled vs. Welch: Which Should You Use?

Feature Pooled t-test Welch t-test
Equal variances assumed? Yes No
Unequal group variances Potential concern Handled directly
Unequal sample sizes More sensitive to variance differences Generally robust
Degrees of freedom \(n_1+n_2-2\) Welch-Satterthwaite approximation
Common modern choice When equal variance is justified Often preferred when variance equality is uncertain
Practical rule: If there is no strong scientific or design reason to assume equal variances, Welch's two-sample t-test is often a sensible choice. The decision should be specified consistently with the statistical analysis plan.

Two-Sample Clinical Example

Suppose a randomized clinical trial compares change from baseline in a continuous biomarker.

Group n Mean change SD
Drug 40 −12.4 18.0
Placebo 40 −4.8 14.0

The estimated treatment difference, defined here as Drug minus Placebo, is:

\[ \widehat{\Delta} = -12.4-(-4.8) = -7.6 \]

Thus, the estimated mean change is 7.6 units lower in the Drug group than in the Placebo group.

Using Welch's method, the standard error is:

\[ SE= \sqrt{ \frac{18^2}{40} + \frac{14^2}{40} } \] \[ SE\approx3.63 \]

The corresponding t-statistic is approximately:

\[ t= \frac{-7.6}{3.63} \approx-2.09 \]

The precise p-value depends on the Welch degrees of freedom.

Direction matters: Always define the treatment difference explicitly. If the estimand is Drug minus Placebo, a negative value indicates a lower mean outcome in the Drug group. Reversing the subtraction reverses the sign but not the underlying strength of evidence.

Confidence Interval for the Difference in Means

For an independent two-sample comparison, the confidence interval is centered on the estimated difference:

\[ (\bar{X}_1-\bar{X}_2) \pm t_{1-\alpha/2,df} \times SE \]

For Welch's test, the standard error and degrees of freedom come from the Welch calculation.

A confidence interval provides three important pieces of information:

  • Direction: whether the estimated difference favors one group or the other.
  • Magnitude: the estimated size of the difference.
  • Precision: how narrowly the plausible values are concentrated.
Clinical interpretation: A statistically significant difference can be clinically unimportant if its magnitude is small. Conversely, a clinically meaningful estimated difference may fail to reach statistical significance when the study is small or the estimate is imprecise.

Paired t-Test

A paired t-test is appropriate when observations occur in natural pairs. Repeated measurements on the same patient are a common clinical example.

Suppose each patient has a baseline measurement and a Week 12 measurement. Define the within-patient difference:

\[ D_i=X_{i,\mathrm{Week\,12}}-X_{i,\mathrm{Baseline}} \]

The paired t-test is then simply a one-sample t-test applied to the differences.

The hypotheses are:

\[ H_0:\mu_D=0 \] \[ H_A:\mu_D\neq0 \]

The test statistic is:

\[ t= \frac{\bar{D}-0}{s_D/\sqrt{n}} \]

with:

\[ df=n-1 \]
Key distinction: The paired t-test does not treat baseline and follow-up measurements as two independent samples. It analyzes the within-patient differences.

Independent vs. Paired Data

Situation Appropriate approach
Drug group vs. independent placebo group Independent two-sample t-test
Patient baseline vs. same patient's follow-up Paired t-test
Matched subjects with one observation in each condition Paired t-test
One group compared with a fixed reference value One-sample t-test

Why Pairing Can Increase Precision

Suppose baseline and follow-up measurements within the same patient are positively correlated.

The variance of a paired difference is:

\[ \operatorname{Var}(D) = \operatorname{Var}(X_{\mathrm{post}}) + \operatorname{Var}(X_{\mathrm{baseline}}) - 2\operatorname{Cov}(X_{\mathrm{post}},X_{\mathrm{baseline}}) \]

Equivalently, in terms of the correlation \(\rho\):

\[ \operatorname{Var}(D) = \sigma_{\mathrm{post}}^2 + \sigma_{\mathrm{baseline}}^2 - 2\rho\sigma_{\mathrm{post}}\sigma_{\mathrm{baseline}} \]

When baseline and follow-up measurements are strongly positively correlated, the variance of the within-patient difference can be substantially smaller than the variance that would result from treating the observations as independent.

Assumptions of the t-Test

The assumptions depend somewhat on which t-test is being used, but several principles are common.

1
Continuous outcome.
The t-test is designed for quantitative measurements such as laboratory values, blood pressure, biomarker concentrations, or change from baseline.
2
Independence.
For an independent two-sample test, observations between groups should be independent according to the study design.
3
Approximately normal sampling behavior.
The t-test relies on the sampling distribution of the relevant mean or mean difference being appropriately represented by the t-distribution.
4
Variance assumption where applicable.
The pooled two-sample t-test assumes equal population variances. Welch's test does not.

Does the Raw Data Have to Be Perfectly Normal?

No. The t-test does not require every observed value to be exactly normally distributed in practice.

The robustness of the method depends on factors such as sample size, the degree of skewness, the presence of extreme observations, and whether the observations are independent.

For sufficiently large samples, the sampling distribution of the mean can be approximately normal under broad conditions.

Clinical-trial perspective: Do not automatically abandon a t-test simply because a histogram is not perfectly bell-shaped. Instead, evaluate the magnitude of skewness, sample size, influential observations, the scientific scale of the endpoint, and the prespecified analysis methodology.

Outliers

Extreme observations deserve particular attention because a mean and standard deviation can be sensitive to outliers.

An unusually large observation should not automatically be deleted simply because it makes a p-value less favorable.

In clinical research, investigate whether the observation represents:

  • A legitimate biological measurement
  • A data-entry error
  • A laboratory or measurement problem
  • A protocol deviation
  • An unusual but clinically plausible response

Any treatment of influential observations should follow the prespecified analysis strategy and appropriate data-review procedures.

One-Sided vs. Two-Sided t-Tests

A two-sided alternative is:

\[ H_A:\mu\neq\mu_0 \]

A one-sided alternative might be:

\[ H_A:\mu>\mu_0 \]

or:

\[ H_A:\mu<\mu_0 \]

The choice should be driven by the scientific question and specified before examining the results.

Do not choose the tail after seeing the data. Changing from a two-sided to a one-sided hypothesis because the observed result went in a desirable direction can invalidate the intended Type I error control.

Relationship Between the t-Test and the Confidence Interval

For a two-sided test at significance level \(\alpha\), the corresponding \(100(1-\alpha)\%\) confidence interval provides an equivalent decision rule for the null value.

For example, when testing:

\[ H_0:\mu_1-\mu_2=0 \]

at \(\alpha=0.05\):

  • If the 95% confidence interval excludes 0, the two-sided p-value is below 0.05.
  • If the 95% confidence interval includes 0, the two-sided p-value is at least 0.05.

The confidence interval, however, communicates substantially more than the binary reject/do-not-reject decision.

Effect Size

A p-value does not quantify the magnitude of a treatment difference. Effect-size measures can provide additional context.

For two groups, one standardized measure is Cohen's \(d\):

\[ d= \frac{\bar{X}_1-\bar{X}_2}{s_p} \]

where \(s_p\) is the pooled standard deviation.

A standardized effect can be useful when comparing effects measured on different scales, although the raw treatment difference is often more directly clinically interpretable.

Clinical-trial principle: Do not substitute a generic effect-size threshold for clinical judgment. Whether a difference is meaningful depends on the endpoint, disease, patient population, treatment context, and prespecified clinical relevance.

Statistical Significance vs. Clinical Significance

Consider two hypothetical results.

Scenario Estimated difference p-value Potential interpretation
A 0.4 units <0.001 Statistically significant but potentially clinically small
B 8.0 units 0.08 Potentially important but imprecisely estimated

These examples illustrate why clinical interpretation should consider the estimated effect and its confidence interval rather than relying exclusively on whether \(p<0.05\).

Change From Baseline in Clinical Trials

A common use of t-tests in clinical data is analysis of change from baseline. For patient \(i\):

\[ CHG_i=POST_i-BASE_i \]

The mean change in a treatment group is:

\[ \overline{CHG} = \frac{1}{n}\sum_{i=1}^{n}CHG_i \]

A one-sample test could evaluate whether the mean change differs from zero.

However, in a randomized controlled trial, the primary treatment comparison is often a comparison between treatment groups rather than simply asking whether one treatment group's change differs from zero.

Important: Testing whether the treatment-group change differs from zero does not directly test whether treatment differs from control. The clinically relevant comparison in a randomized trial is often the between-group treatment contrast.

Why "Significant Within Treatment but Not Between Treatment" Can Happen

Suppose the treatment group has a statistically significant mean change from baseline, while the control group does not.

It is incorrect to conclude automatically that the treatment is superior to control.

The appropriate question is whether the difference between the groups is statistically and clinically supported.

In symbols, the relevant contrast is:

\[ \Delta= \mu_{\mathrm{Treatment}} - \mu_{\mathrm{Control}} \]

rather than testing the two within-group changes independently.

Classic statistical mistake: "Significant in one group but not significant in the other" does not imply that the two groups are significantly different from each other.

Baseline Adjustment and ANCOVA

Although a t-test can compare change from baseline, clinical-trial analyses sometimes use a regression or ANCOVA framework that adjusts for baseline.

A simple ANCOVA model can be written as:

\[ Y_{\mathrm{post},i} = \beta_0 + \beta_1 Treatment_i + \beta_2 Baseline_i + \epsilon_i \]

Here, \(\beta_1\) represents the treatment effect conditional on baseline.

The choice between a simple t-test on change and a baseline-adjusted model depends on the endpoint, design, analysis plan, efficiency considerations, and regulatory/statistical expectations.

Do not treat every clinical-trial comparison as a t-test problem. The t-test is useful for simple continuous comparisons, but randomized clinical trials frequently require models that account for baseline covariates, stratification, repeated measurements, missing data, or other design features.

When a t-Test May Not Be Appropriate

A t-test may be unsuitable or incomplete when the endpoint or study design has features such as:

  • Highly skewed continuous data requiring a different analysis strategy
  • Ordinal outcomes
  • Binary or categorical outcomes
  • Time-to-event endpoints
  • Repeated longitudinal measurements
  • Clustered observations
  • Substantial informative missingness
  • Complex covariate adjustment

For example, a survival endpoint such as time to disease progression is not appropriately analyzed with a simple two-sample t-test because the statistical structure is fundamentally different.

Nonparametric Alternatives

When a t-test is not appropriate because of the endpoint characteristics or analysis assumptions, nonparametric methods may sometimes be considered.

Situation Possible method
One-sample continuous/ordinal comparison Wilcoxon signed-rank test
Two independent groups Wilcoxon rank-sum test
Paired observations Wilcoxon signed-rank test

These methods do not simply represent "the same t-test without the normality assumption." They generally address different statistical quantities and should be interpreted accordingly.

Implementation in R

One-Sample t-Test

Suppose the variable change contains change from baseline.

t.test(change, mu = 0)

This tests:

\[ H_0:\mu=0 \]

Two-Sample Welch t-Test

Suppose change is the continuous endpoint and treatment identifies the two groups.

t.test(change ~ treatment,
       data = analysis_data,
       var.equal = FALSE)

The argument:

var.equal = FALSE

requests Welch's unequal-variance version.

Pooled Two-Sample t-Test in R

t.test(change ~ treatment,
       data = analysis_data,
       var.equal = TRUE)

The distinction is important because the two commands correspond to different variance assumptions.

Paired t-Test in R

For paired baseline and follow-up measurements:

t.test(
  analysis_data$week12,
  analysis_data$baseline,
  paired = TRUE
)

Equivalently, the analysis can be expressed explicitly in terms of patient-level differences:

analysis_data$change <-
  analysis_data$week12 -
  analysis_data$baseline

t.test(analysis_data$change, mu = 0)
Why these are equivalent: A paired t-test is mathematically a one-sample t-test applied to the within-pair differences.

Implementation in SAS

One-Sample t-Test

A one-sample t-test can be performed with PROC TTEST.

proc ttest data=analysis_data h0=0;
    var change;
run;

Here, h0=0 specifies the hypothesized population mean.

Two-Sample t-Test

proc ttest data=analysis_data;
    class treatment;
    var change;
run;

SAS provides results for the relevant two-group comparisons, including tests under different variance assumptions.

Paired t-Test

proc ttest data=analysis_data;
    paired week12*baseline;
run;

This evaluates the mean within-patient difference.

Clinical-Trial Reporting

A useful statistical presentation should generally include more than a p-value. For a two-group continuous endpoint, a concise presentation might include:

Component Purpose
Sample size Shows the number of analyzed patients
Mean Describes the central tendency
Standard deviation Describes variability
Estimated treatment difference Quantifies the between-group effect
95% confidence interval Shows precision and plausible effect sizes
p-value Quantifies evidence against the specified null hypothesis

For example, a clinical report might describe a treatment difference as:

Example reporting structure: The mean change from baseline was −12.4 units in the treatment group and −4.8 units in the control group, corresponding to an estimated treatment difference of −7.6 units. The 95% confidence interval and p-value should be reported alongside this estimate.

Common Mistakes

1. Using a Two-Sample Test for Paired Data

Treating repeated measurements from the same patient as independent observations ignores the pairing structure.

2. Testing Each Treatment Group Against Zero

In a randomized trial, the scientifically relevant question is often the between-treatment contrast rather than whether each group individually changed from baseline.

3. Automatically Assuming Equal Variances

The pooled test requires an equal-variance assumption. Welch's method avoids that requirement.

4. Reporting Only the p-Value

A p-value does not communicate the size or precision of the treatment effect.

5. Ignoring the Direction of the Contrast

A treatment difference should be defined explicitly, such as:

\[ \Delta= \mu_{\mathrm{Drug}} - \mu_{\mathrm{Placebo}} \]

Otherwise, the sign of the reported estimate can be misinterpreted.

6. Calling a Result Clinically Important Because It Is Significant

Statistical significance and clinical importance are different concepts.

7. Changing the Analysis After Seeing the Data

The test type, sidedness, estimand, population, and handling of important data features should be specified according to the statistical analysis plan rather than selected opportunistically after observing the results.

A Practical Decision Framework

1
What is the scientific question?
Are you comparing one mean with a fixed reference, comparing two groups, or evaluating within-subject change?
2
Are the observations independent?
If the same patients contribute observations under two conditions, consider a paired analysis rather than an independent two-sample test.
3
What is the estimand?
Define precisely what difference or mean is being estimated and the direction of the contrast.
4
Is a simple t-test appropriate?
Consider the endpoint distribution, study design, repeated measurements, covariates, missing data, and prespecified analysis methodology.
5
Choose the appropriate test.
Use a one-sample, independent two-sample, Welch, pooled, or paired t-test as appropriate.
6
Report the estimate and uncertainty.
Present the estimated mean or treatment difference, confidence interval, sample size, and p-value.

Worked Comparison of the Three Tests

Question Null hypothesis Typical test statistic
Does one mean equal 0? \(H_0:\mu=0\) \(\frac{\bar X}{s/\sqrt n}\)
Do two independent means differ? \(H_0:\mu_1-\mu_2=0\) \(\frac{\bar X_1-\bar X_2}{SE}\)
Does mean within-patient change equal 0? \(H_0:\mu_D=0\) \(\frac{\bar D}{s_D/\sqrt n}\)

The Most Important Concept

The most important step in applying a t-test is not calculating the t-statistic. It is identifying the correct comparison.

A useful way to think about the three common settings is:

A
One sample:
Is the population mean different from a specified value?
B
Two independent samples:
Is the population mean in Group 1 different from the population mean in Group 2?
C
Paired observations:
Is the mean within-pair difference different from zero?

Once the comparison is correctly defined, the mathematics follows naturally.

Key Takeaways

One-sample t-test: compares one sample mean with a specified reference value.

Independent two-sample t-test: compares means from two independent groups.

Welch t-test: compares two independent means without assuming equal population variances.

Paired t-test: analyzes within-pair differences and is equivalent to a one-sample t-test on those differences.

Confidence intervals: show the magnitude and precision of the estimated effect and should generally accompany hypothesis tests.

Clinical significance: should not be inferred from statistical significance alone.

Clinical-trial analysis: the t-test is useful for appropriate continuous endpoints, but more complex designs may require regression, ANCOVA, mixed models, survival analysis, or other methods.

Summary

The t-test remains an important tool for clinical statisticians because many clinical research questions involve means of continuous measurements.

The one-sample t-test evaluates a mean against a specified reference. The independent two-sample t-test compares means between two independent groups, with Welch's version avoiding the equal-variance assumption required by the pooled test. The paired t-test handles naturally paired observations by reducing the analysis to a one-sample test of within-pair differences.

In clinical trials, however, the statistical test should follow the scientific question and prespecified analysis strategy. A p-value alone is rarely enough. The estimated treatment difference, confidence interval, variability, sample size, and clinical relevance should all contribute to interpretation.

Understanding these distinctions allows the t-test to be used appropriately rather than simply applied whenever two means appear in a dataset.

Clinical Trials

See t-test in real clinical trials

See the method applied to published trial results, with the estimates, confidence intervals and interpretation explained.

SWOG 9346
Independent statistical analysis of SWOG 9346, a randomized phase 3 trial of intermittent versus continuous hormonal therapy in men with stage IV…
Phase 3 · n = 3,040
iPrEx
Independent statistical analysis of the randomized phase 3 iPrEx trial of daily TDF/FTC versus placebo for HIV prevention in men, including primary…
Phase 3 · n = 2,499
FEM-PrEP
Independent statistical analysis of FEM-PrEP, a randomized phase 3 trial evaluating Truvada versus placebo for preventing HIV acquisition in women, including its…
Phase 3 · n = 2,120
KEYNOTE-671
Independent statistical analysis of KEYNOTE-671, a randomized phase 3 trial of pembrolizumab with platinum-doublet chemotherapy as neoadjuvant/adjuvant therapy for resectable stage II,…
Phase 3 · n = 797
COSS
Independent statistical analysis of the COSS phase 3 trial of extracranial-intracranial bypass surgery versus best medical therapy for symptomatic carotid occlusion, including…
Phase 3 · n = 700
CRYSTAL-AF
Independent statistical analysis of CRYSTAL-AF, evaluating continuous cardiac monitoring with an insertable cardiac monitor for atrial fibrillation detection after cryptogenic stroke or…
Phase 4 · n = 447
See all 8 trials using t-test →